DK1593670T3 - Hydroxysubstituerede 2-azetidinoner, der er anvendelige som hypokolesterolæmiske midler - Google Patents

Hydroxysubstituerede 2-azetidinoner, der er anvendelige som hypokolesterolæmiske midler

Info

Publication number
DK1593670T3
DK1593670T3 DK05004699T DK05004699T DK1593670T3 DK 1593670 T3 DK1593670 T3 DK 1593670T3 DK 05004699 T DK05004699 T DK 05004699T DK 05004699 T DK05004699 T DK 05004699T DK 1593670 T3 DK1593670 T3 DK 1593670T3
Authority
DK
Denmark
Prior art keywords
hydroxy
substituted
hypocholesterolemic agents
azetidinones useful
azetidinones
Prior art date
Application number
DK05004699T
Other languages
Danish (da)
English (en)
Inventor
Anima Ghosal
Shmuel Zbaida
Swapan K Chowdhury
Robert M Iannucci
Wenqing Feng
Kevin B Alton
James E Patrick
Harry R Davis
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22973953&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1593670(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK1593670T3 publication Critical patent/DK1593670T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK05004699T 2000-12-20 2001-12-17 Hydroxysubstituerede 2-azetidinoner, der er anvendelige som hypokolesterolæmiske midler DK1593670T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25687500P 2000-12-20 2000-12-20
PCT/US2001/049127 WO2002050090A1 (fr) 2000-12-20 2001-12-17 2-azetidinones substitues par le sucre utilises comme hypocholesterolemiants

Publications (1)

Publication Number Publication Date
DK1593670T3 true DK1593670T3 (da) 2007-11-05

Family

ID=22973953

Family Applications (2)

Application Number Title Priority Date Filing Date
DK05004699T DK1593670T3 (da) 2000-12-20 2001-12-17 Hydroxysubstituerede 2-azetidinoner, der er anvendelige som hypokolesterolæmiske midler
DK01991315T DK1347987T3 (da) 2000-12-20 2001-12-17 Sukkersubstituerede 2-azetidinoner, der er anvendelige som hypocholesterolæmiske midler

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK01991315T DK1347987T3 (da) 2000-12-20 2001-12-17 Sukkersubstituerede 2-azetidinoner, der er anvendelige som hypocholesterolæmiske midler

Country Status (35)

Country Link
US (1) US20020137690A1 (fr)
EP (1) EP1347987B1 (fr)
JP (2) JP4351842B2 (fr)
KR (1) KR100883461B1 (fr)
CN (1) CN100475829C (fr)
AR (1) AR035611A1 (fr)
AT (2) ATE369334T1 (fr)
AU (2) AU2002231049B2 (fr)
BR (1) BR0116212A (fr)
CA (1) CA2432798C (fr)
CY (1) CY1106912T1 (fr)
CZ (1) CZ302193B6 (fr)
DE (2) DE60129863T2 (fr)
DK (2) DK1593670T3 (fr)
EC (1) ECSP034659A (fr)
ES (2) ES2230385T3 (fr)
GE (1) GEP20053548B (fr)
HK (2) HK1056735A1 (fr)
HU (1) HUP0302269A3 (fr)
IL (1) IL155771A0 (fr)
MA (1) MA26975A1 (fr)
MX (1) MXPA03005671A (fr)
MY (1) MY129148A (fr)
NO (2) NO326981B1 (fr)
NZ (1) NZ525722A (fr)
PE (1) PE20020718A1 (fr)
PL (1) PL208242B1 (fr)
PT (2) PT1593670E (fr)
RU (1) RU2297422C2 (fr)
SI (2) SI1593670T1 (fr)
SK (1) SK286703B6 (fr)
TR (1) TR200402758T4 (fr)
TW (1) TWI316942B (fr)
WO (1) WO2002050090A1 (fr)
ZA (1) ZA200303694B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ304929B6 (cs) 2001-03-28 2015-01-28 Merck Sharp & Dohme Corp. Enantioselektivní syntéza azetidinonových meziproduktů
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
AR040588A1 (es) 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
JP2005015434A (ja) * 2003-06-27 2005-01-20 Kotobuki Seiyaku Kk 血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
EP1522541A1 (fr) * 2003-10-07 2005-04-13 Lipideon Biotechnology AG Nouveaux composés hypocholesterolémiques
EP1918000A2 (fr) 2003-11-05 2008-05-07 Schering Corporation Combinaisons d'agents de modulation lipide et azétidinones substitués et traitements pour conditions vasculaires
WO2005061452A1 (fr) * 2003-12-23 2005-07-07 Astrazeneca Ab Derives diphenylazetidinone a activite inhibitrice de l'absorption du cholesterol
JP2007516287A (ja) 2003-12-23 2007-06-21 メルク　エンド　カムパニー　インコーポレーテッド 抗高コレステロール血症化合物
GB0329778D0 (en) * 2003-12-23 2004-01-28 Astrazeneca Ab Chemical compounds
MX2007003732A (es) * 2004-09-29 2007-04-23 Schering Corp Combinaciones de azetidononas sustituidas y antagonistas de receptor de canabinoide 1.
US7737155B2 (en) 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
AR054482A1 (es) * 2005-06-22 2007-06-27 Astrazeneca Ab Derivados de azetidinona para el tratamiento de hiperlipidemias
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
KR20080096851A (ko) * 2006-03-06 2008-11-03 테바 파마슈티컬 인더스트리즈 리미티드 에제티미베 조성물
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
CN101652377A (zh) * 2007-04-02 2010-02-17 泰拉科斯有限公司 苄基化糖苷衍生物及其用法
US20110245209A1 (en) 2008-12-16 2011-10-06 Schering Corporation Pyridopyrimidine derivatives and methods of use thereof
US20110243940A1 (en) 2008-12-16 2011-10-06 Schering Corporation Bicyclic pyranone derivatives and methods of use thereof
CN102388059B (zh) * 2009-02-11 2015-03-04 陶氏益农公司 杀虫组合物
CA2754384A1 (fr) 2009-03-06 2010-09-10 Lipideon Biotechnology Ag Compositions pharmaceutiques hypocholesterolemiques
WO2010113175A2 (fr) 2009-04-01 2010-10-07 Matrix Laboratories Ltd Procédé enzymatique pour la préparation de la (s)-5-(4-fluorophényl)-5-hydroxy-1-morpholin-4-yl-pentan-1-one, un intermédiaire de l'ézétimibe et la conversion ultérieure en ézétimibe
CN101993403B (zh) 2009-08-11 2012-07-11 浙江海正药业股份有限公司 氮杂环丁酮类化合物及医药应用
KR101102749B1 (ko) * 2009-11-30 2012-01-05 최길용 곱셈 학습기
KR20150079373A (ko) 2013-12-30 2015-07-08 한미약품 주식회사 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제
CN105055404B (zh) * 2015-08-19 2017-07-18 四川大学 Hmgcs2抑制剂在制备治疗可卡因成瘾的药物中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3595B (en) * 1993-01-21 1995-12-27 Schering Corp Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US5627176A (en) * 1994-03-25 1997-05-06 Schering Corporation Substituted azetidinone compounds useful as hypocholesterolemic agents
US5633246A (en) * 1994-11-18 1997-05-27 Schering Corporation Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
CZ293957B6 (cs) * 1995-10-31 2004-08-18 Scheringácorporation @@Azetidinony substituované cukernými zbytkyŹ použitelné jako hypocholesterolemikaŹ farmaceutický prostředek a kit je obsahující
US5756470A (en) * 1996-10-29 1998-05-26 Schering Corporation Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
AUPQ342599A0 (en) * 1999-10-14 1999-11-04 University Of Melbourne, The Conjugates and uses thereof

Also Published As

Publication number Publication date
JP2004516299A (ja) 2004-06-03
WO2002050090A1 (fr) 2002-06-27
WO2002050090A8 (fr) 2004-04-15
GEP20053548B (en) 2005-06-27
MXPA03005671A (es) 2003-10-06
AR035611A1 (es) 2004-06-16
CZ302193B6 (cs) 2010-12-08
CA2432798A1 (fr) 2002-06-27
PT1593670E (pt) 2007-11-08
KR20030063414A (ko) 2003-07-28
PL208242B1 (pl) 2011-04-29
NO20032806D0 (no) 2003-06-19
NO20083737L (no) 2003-08-19
EP1347987A1 (fr) 2003-10-01
ES2287826T3 (es) 2007-12-16
AU2002231049B2 (en) 2006-07-20
NO326981B1 (no) 2009-03-30
BR0116212A (pt) 2003-12-30
MY129148A (en) 2007-03-30
JP2009132745A (ja) 2009-06-18
NZ525722A (en) 2004-11-26
JP4351842B2 (ja) 2009-10-28
MA26975A1 (fr) 2004-12-20
ATE369334T1 (de) 2007-08-15
CN1483039A (zh) 2004-03-17
KR100883461B1 (ko) 2009-02-16
TWI316942B (en) 2009-11-11
RU2297422C2 (ru) 2007-04-20
ECSP034659A (es) 2003-07-25
CY1106912T1 (el) 2012-09-26
PT1347987E (pt) 2005-01-31
SK7702003A3 (en) 2003-10-07
CZ20031674A3 (cs) 2003-10-15
IL155771A0 (en) 2003-12-23
TR200402758T4 (tr) 2004-11-22
DE60129863D1 (de) 2007-09-20
DE60129863T2 (de) 2008-04-30
DE60106489T2 (de) 2005-10-13
HK1084945A1 (en) 2006-08-11
PL363237A1 (en) 2004-11-15
SK286703B6 (sk) 2009-03-05
AU3104902A (en) 2002-07-01
ES2230385T3 (es) 2005-05-01
HUP0302269A3 (en) 2009-08-28
ZA200303694B (en) 2004-08-13
HK1056735A1 (en) 2004-02-27
PE20020718A1 (es) 2002-08-09
CA2432798C (fr) 2007-02-27
EP1347987B1 (fr) 2004-10-13
SI1593670T1 (sl) 2007-12-31
US20020137690A1 (en) 2002-09-26
HUP0302269A2 (hu) 2003-10-28
CN100475829C (zh) 2009-04-08
DK1347987T3 (da) 2005-01-31
NO20032806L (no) 2003-08-19
DE60106489D1 (de) 2004-11-18
RU2003122520A (ru) 2005-02-27
ATE279425T1 (de) 2004-10-15
SI1347987T1 (en) 2005-02-28

Similar Documents

Publication Publication Date Title
DK1593670T3 (da) Hydroxysubstituerede 2-azetidinoner, der er anvendelige som hypokolesterolæmiske midler
NO20031001D0 (no) Polyarylkarboksamider nyttige som lipidsenkende midler
IS6971A (is) Ný efnasambönd
DE60225341D1 (de) Neue 1,2,4-triazolverbindung
AR027983A1 (es) Novedosos compuestos
DK1339685T3 (da) Biphenylcarboxamider, der er egnede som lipidsænkende midler
PT1299356E (pt) Novos compostos
AR028220A1 (es) Novedosos compuestos
DE60111547D1 (de) Dämpfermechanismus
ITUD20000151A1 (it) Centratore per levetappi
AR028399A1 (es) Nuevos compuestos
DK1497256T3 (da) Substituerede 1,5-diaminopentan-3-ol-forbindelser
ES1047687Y (es) Panel mejorado para la construccion.
ITBO20000530A0 (it) Macchina sezionatrice di pannelli
ITBO20000531A0 (it) Macchina sezionatrice di pannelli
FIU20010378U0 (fi) Sahalaitteisto
DE60224192D1 (de) Antihaemorrhagische, betain-enthaltende zusammenseuzungen
IT1315718B1 (it) Meccanismo oscillante per giostrine.
SE0004680D0 (sv) New compound
SE0003640D0 (sv) New compounds
IS8579A (is) Ný efnasambönd
AR027949A1 (es) Novedosos compuestos
SE0104366D0 (sv) New compounds
SE0101660D0 (sv) New compounds
SE0102386D0 (sv) New compounds